In patients with diabetes, hospitalization can complicate the achievement of recommended glycemic targets. There is increasing evidence that a closed-loop delivery system (artificial pancreas) can ...

Currently, one closed-loop system, the Medtronic MiniMed 670G, is in commercial use in the United States, but randomized trials are needed to assess its efficacy and safety. 8 Such a system, which ...

In a recent study published in Nature Medicine, researchers investigated whether completely closed-loop insulin delivery could improve glycemic control among type 2 diabetes patients compared to ...